Posts filtered by tags: Center For Medicare And Medicaid Services[x]


 

Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More

While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb’s proposal to buy Celgene for $74 billion, it wasn’t that long ago that another company’s gaze was fixed on the Summit, NJ, drug maker.In the early 2000s, before the FDA approved Celgene’s flagship multiple myeloma drug lenalidomide (Revlimid), Novartis (NYSE: NVS considered buying the company. It passed, unwilling to risk billions on an unapproved drug. Those details came from biopharma dealmaker George...
Tags: Deals, Startups, China, Ipo, Cancer, Trends, Investing, Merck, Colorectal Cancer, Multiple Sclerosis, Harvard University, Health Insurance, Astrazeneca, Center For Medicare And Medicaid Services, Fda, National


In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine

Roche this morning agreed to acquire the part of Foundation Medicine it didn’t already own, another big vote of confidence in tests that analyze a patient’s cancer genes and the drugs that can target them. Roche will pay $137 per share, or $2.4 billion, for the remaining stock of Foundation (NASDAQ: FMI), of Cambridge, MA. Roche already held a majority of Foundation’s shares through a wide-ranging alliance announced in January 2015. Today’s purchase values the company at $5.3 billion. Sha...
Tags: Deals, Boston, Cancer, Trends, Center For Medicare And Medicaid Services, Fda, Biotech, Life Sciences, Foundation, Genentech, Roche, Foundation Medicine, FoundationOne Heme, National blog main, New York blog main, Boston blog main


Iris Plans Uses Telemedicine to Innovate Delivery of End-of-life Care

Austin—Iris Plans is using telemedicine for an often overlooked part of health care: advanced care planning. Iris recently announced a partnership with the University of Utah Health Plans, and is now providing technology-enabled advanced care planning for about 50,000 members. Iris has created an online office where doctors, nurses, or social workers can advise patients and their families about forming a plan for end-of-life care. “Towards the end of life, many patients get care that they...
Tags: Cake, Startups, Texas, Boston, Trends, App, Austin, Healthcare, Innovation, Venture Capital, Center For Medicare And Medicaid Services, Biotech, Oakland, Iris, Telemedicine, Palliative Care


The Medicare drug subsidy that millions of enrollees overlook

Photo by Flickr user goldlionpics. Editor’s Note: The open enrollment period for Medicare extends to Dec. 7. To help readers navigate this complicated process, Making Sen$e turns to journalist Philip Moeller, who writes widely on health and retirement, to answer your Medicare questions in a new column on this page, “Ask Phil, the Medicare Maven.” Read Phil’s past columns and keep sending your questions. Phil Moeller is a research fellow at the Center on Aging & Work at Boston College and co-au...
Tags: Personal Finance, Washington, Making Sen$e, Social Security, Center For Medicare And Medicaid Services, Medicare, Medicare Advantage Program, Medicare Drug Bill, Open Enrollment, Subsidies, Don, Phil, Medicare Advantage, Congressional Budget Office, Philip Moeller, Phil Moeller